Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2003

View Archived Issues

Cangene awarded NIAID funding for Burkholderia antibody development

IsoTis and GenSci OrthoBiologics complete merger

Potential new therapeutic indications described for adalimumab

Combination of UDCA and MMF in the treatment of sclerosing cholangitis

SBIR grant supports investigation of A2AAR agonists for anthrax septicemia

Phase III results for G17DT in pancreatic cancer

Boston Life Sciences to submit modified phase III protocol for Altropane

Medarex and Avalon collaborate on antibody development

Collaboration to test MVA-BN with HER-2 DNA AutoVac vaccine

Indian researchers report a potential antidiabetic agent from plant extracts

XenoPort claims new prodrugs of GABA analogues for use in pain and epilepsy

Tissue-selective ERalpha antagonists prepared and tested at Schering AG

New cytochrome P-450RAI inhibitors and their use patented by Allergan

Novel P2Y1 antagonists described by Bayer researchers

Boehringer Ingelheim patent covers new HIV RT inhibitors

Novel chymase inhibitors under study at Toa Eiyo

No increase in CHF risk during anti-TNF-alpha therapy in patients with rheumatoid arthritis

Yamanouchi presents new mGluR modulators with utility in pain and other disorders

Teriparatide reported to induce long-term back pain relief in osteoporosis

Bosentan effective in digital ulcers associated with systemic sclerosis

Improved outcome reported with tight control of disease activity in rheumatoid arthritis

Clinical trial evaluates CC-8490 for brain cancer

Approvable letter for Ranexa

NIH grant supports investigation of PARS inhibition for acute smoke inhalation

3rd Annual Biotech in Europe Investor Forum to be broadcast

Potent Tie-2 inhibitors discovered to be effective in models of angiogenesis

K-10191: a new ACAT inhibitor with selectivity for aorta

AIMECS 03 news: di- and tripeptide HIV-1 protease inhibitors with potent antiviral activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...